Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Sprinter Sha'Carri Richardson apologizes after domestic incident, vows to face consequences and grow as a person.
Video captures Israeli settler fatally shooting Palestinian activist in West Bank
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Sprinter Sha'Carri Richardson apologizes after domestic incident, vows to face consequences and grow as a person.
Video captures Israeli settler fatally shooting Palestinian activist in West Bank